Megan Vignos

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Respiratory Syndrome Coronavirus

Cross Sectional

Top Venues

Multiple sclerosis journal - experimental, translational and clinical

Advances in therapy

Drugs - real world outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Salvetti, Sibyl Wray, Gereon Nelles, Nicholas Belviso, Achint Kumar, Thijs Koster, Wanda Castro-Borrero, Megan Vignos, null null
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program. Multiple sclerosis journal - experimental, translational and clinical 10 (2) (2024)
Marco Salvetti, Sibyl Wray, Gereon Nelles, Nicholas Belviso, Achint Kumar, Thijs Koster, Wanda Castro-Borrero, Megan Vignos, null null
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program. Multiple sclerosis journal - experimental, translational and clinical 10 (2) (2024)
Bianca Weinstock-Guttman, Amy Perrin Ross, Jonathan Planton, Kurt White, Avni Pandhi, Andres Greco, Achint Kumar, Nicholas Everage, Megan Vignos
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX ® Pregnancy Exposure Registry. Drugs - real world outcomes (2023)
Hayrettin Tumani, Patricia K Coyle, Claudia Cárcamo, Cinzia Cordioli, Pablo A López, Marek Peterka, Cristina Ramo-Tello, María I Zuluaga, Thijs Koster, Megan Vignos
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey. Multiple sclerosis journal - experimental, translational and clinical 9 (3) (2023)
Patricia K Coyle, Anne Gocke, Megan Vignos, Scott D Newsome
Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era. Advances in therapy 38 (7) (2021)
Patricia K Coyle, Anne Gocke, Megan Vignos, Scott D Newsome
Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era. Advances in therapy (2021)